Loading...

Quest Diagnostics Incorporated

DGX•NYSE
Healthcare
Medical - Diagnostics & Research
$196.27
$-3.26(-1.63%)
U.S. Market opens in 23h 3m

Quest Diagnostics Incorporated (DGX) Stock Overview

Explore Quest Diagnostics Incorporated’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap21.7B
P/E Ratio21.09
EPS (TTM)$9.06
ROE0.14%
Fundamental Analysis

AI Price Forecasts

1 Month$199.87
3 Months$202.30
1 Year Target$186.36

DGX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Quest Diagnostics Incorporated (DGX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 47.86, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $186.36.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 21.09 and a market capitalization of 21.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.65%
5-Day Change
3.15%
1-Month Change
0.08%
3-Month Change
8.40%
6-Month Change
7.71%
Year-to-Date (YTD) Change
13.08%
1-Year Change
11.58%
3-Year Change
33.90%
5-Year Change
48.36%
All-Time (Max) Change
5506.57%

Contact Information

https://www.questdiagnostics.com
973 520 2700
500 Plaza Drive, Secaucus, NJ, 07094

Company Facts

55,000 Employees
IPO DateDec 17, 1996
CountryUS
Actively Trading

Frequently Asked Questions